Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.
Re:infer is an enterprise intelligence system that makes communications data understood and actionable. Building on the advances in deep learning and natural language understanding the turn unstructured communications data like emails, calls, messaging, reviews, social, and logs into structured, annotated data at scale. The clients use re:infer to unlock detailed insights into customer behaviour, operations, and to drive automation. Re:infer is a spinout from UCL, a global centre for artificial intelligence research, is backed by Seedcamp Europe's leading early stage investment fund and some of Europe’s most successful AI entrepreneurs. Re:infer is headquartered in London England.
SAM Labs Limited is an education technology company based in London that specializes in providing innovative teaching resources for educators. Founded in 2014, the company offers a range of products, including wireless electronic blocks, buttons, sensors, motors, and sliders, which can be connected and programmed using their SAM Space software application. This platform enables students to visualize and code the blocks in an intuitive manner, fostering an engaging STEAM learning experience. SAM Labs provides curriculum-based lesson plans and hands-on support for educators, making coding and computational skills accessible and interactive. Their offerings include course kits and electronic products available for purchase online, allowing educators to create a dynamic classroom environment where students can design, write, and debug their own programs, while learning essential concepts such as sequencing, selection, and logical reasoning.
Oxford Biotrans Limited is a company based in Abingdon, United Kingdom, specializing in the development, production, and commercialization of high-value chemical compounds through innovative enzyme technology. Founded in 2013, the company utilizes patented cytochrome P450 enzyme technology, which is backed by over 15 years of research from Dr. Luet Lok Wong of the University of Oxford. Its flagship product is Nootkatone, a natural grapefruit flavor and scent derived from the biotransformation of Valencene, a citrus extract. Oxford Biotrans is focused on bringing to market a range of flavors and fragrances, while also exploring applications of its technology in the production of pheromones, pharmaceuticals, and other specialty chemicals.
Featurespace is the world-leader in Adaptive Behavioural Analytics and creator of the ARIC™ platform, a machine learning software system developed out of the University of Cambridge. The ARIC™ platform uses anomaly detection to analyse complex behavioural data in real time, spotting anomalies to block new fraud attacks as they occur. At the same time, Featurespace recognises genuine customers without blocking their activity. ARIC™ reduces the number of genuine transactions incorrectly identified as fraud by over 70%, enabling businesses to accept more revenue.
Head quartered in Cambridge, UK, and Atlanta, GA, U.S. Featurespace has deployed the ARIC™ platform to organisations that have services or products deployed in over 180 countries. Customers include Betfair, Vocalink/Zapp, Worldpay, and TSYS, the largest third-party processor of Visa® and MasterCard® credit cards in the U.S.
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.
WaveOptics, Ltd. specializes in the design and manufacture of augmented reality display technology, focusing on optical waveguides for wearable devices. The company offers features such as binocular displays, high field-of-view, and full RGB color in lightweight designs. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, WaveOptics has established strategic partnerships with companies like Compal, Wistron, and Plessey to enhance its product offerings. The company aims to be a pivotal supplier of optical components for the growing augmented reality market.
Yoyo Wallet Limited is a mobile wallet provider based in London, United Kingdom, founded in 2013. The company offers a digital payment platform that facilitates customer transactions through smartphones, allowing users to pay for goods while simultaneously collecting loyalty rewards. Yoyo Wallet serves a variety of clients including retailers, universities, and corporate locations across the UK. The platform processes over 150,000 monthly in-store transactions and features a marketing component that enhances digital customer engagement. By leveraging purchasing patterns, Yoyo enables retailers to deliver personalized rewards and offers, transforming anonymous shoppers into identifiable customers. This approach helps retailers better target their audience and improve customer loyalty. Yoyo Wallet was previously known as JustYoyo Limited until its name change in April 2015.
Impression Technologies Limited, established in 2012 and based in London, specializes in the marketing and commercialization of its innovative Hot Form Quench (HFQ) technology. This technology allows for the efficient formation of aluminum panels into complex shapes, catering to various engineering needs. The company offers a comprehensive service that spans from concept development to production, providing the necessary expertise to support clients in utilizing HFQ technology effectively. Impression Technologies operates a fully equipped facility in Coventry, UK, where it conducts in-house prototyping and production runs to meet the demands of its HFQ customers and partners.
Concirrus Ltd. operates a cloud-based platform that connects various data sources and devices, enabling the management and organization of information from products and machines linked through the Internet. Founded in 2012, the company specializes in leveraging Internet of Things (IoT) data to transform businesses across multiple sectors, including healthcare, security, mining, insurance, and energy. Concirrus offers a range of custom solutions, including consultancy, planning, implementation, and support services, alongside pre-built applications for asset security, fleet management, smart energy, and patient monitoring. Their focus extends to providing insights and rating factors for the insurance industry, employing advanced analytics and machine learning to enhance risk management and operational efficiency. Additionally, Concirrus operates an incident monitoring center for theft recovery and asset security. The company is headquartered in London and has established strategic partnerships to further its technological offerings.
Cardian
Seed Round in 2017
Cardian has been formed to commercialise a novel implantable device that improves the monitoring and treatment of cardiac failure patients, by providing completely automated, continuous wireless monitoring of blood pressure in the pulmonary artery. Following this investment, Innovations will hold a 53.7% interest in the Company, comprising a combination of founders equity and 27.3% derived from investment.
Cortexica Vision Systems Ltd is a London-based company that specializes in vision-based analytics and artificial intelligence solutions tailored for various industries, including retail, media, manufacturing, and pharmaceuticals. Established in 2008, the company offers advanced visual search and image recognition technologies that enhance the digital shopping experience by enabling product discovery and personalization for e-commerce. Its AI-driven tools automate retail operations, improving efficiency and reducing costs. Cortexica also provides a range of video solutions for real-time monitoring and compliance, such as AI-PPE compliance detection and CCTV systems that predict and identify unusual behaviors. Additionally, the company offers edge solutions that facilitate local processing and video analysis. Originating from research at the Bioengineering Department of Imperial College London, Cortexica is designed to adapt to specific client needs, ensuring effective integration and optimal return on investment. It operates as a subsidiary of Zebra Technologies Corporation.
Pulmocide Ltd is a London-based company established in 2007 that specializes in developing inhaled medicines aimed at treating serious viral and fungal infections of the respiratory tract. The company focuses on creating a new generation of antifungal drugs tailored for inhalation, which enhances the delivery of medication directly to the lungs while reducing systemic exposure. This targeted approach is designed to improve efficacy against respiratory aspergillosis and minimize systemic toxicities, thereby offering safe and effective treatment options for patients with acute and chronic respiratory diseases.
Pulmocide Ltd is a London-based company established in 2007 that specializes in developing inhaled medicines aimed at treating serious viral and fungal infections of the respiratory tract. The company focuses on creating a new generation of antifungal drugs tailored for inhalation, which enhances the delivery of medication directly to the lungs while reducing systemic exposure. This targeted approach is designed to improve efficacy against respiratory aspergillosis and minimize systemic toxicities, thereby offering safe and effective treatment options for patients with acute and chronic respiratory diseases.
Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease. Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer. Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.
Resolver is a unique, independent online resolution service. We offer one place and one process to connect consumers directly to the people who can resolve their customer service issues. Our system is focused on communication and fair, efficient resolution. We help consumers get their voices heard effectively, so businesses get their issues resolved more efficiently. This way, the consumer is happy with the outcome and the business retains the customer. The Resolver platform offers fully online, end-to-end arbitration and dispute resolution, providing a fast and cost-efficient way to resolve disputes between two third parties. For businesses, Resolver offers value-added services, providing an enhanced issue-resolution process and real-time consumer feedback insight at every touchpoint using advanced AI programming systems.
Garrison Technology Limited develops technologies for enterprise cybersecurity needs. The company was incorporated in 2014 and is based in London, United Kingdom. It aims to serve the growing enterprise market with its anti-malware product. It wants to address the large and growing enterprise cyber security market. The company has pioneered in an anti-malware product that efficiently sidesteps the highest impact cyber threats to modern organizations, i.e. internet-borne targeted attacks. Due to Garrison’s unique technology, a previously inconceivable brand of ultra-secure internet connectivity, user experience, and enterprise scalability can be achieved.
Veryan was formed in 2003 as the result of a technology spin out from Imperial College, London, UK. Veryan has designed, patented and developed a highly innovative three dimensional (3D) Nitinol (nickel-titanium alloy) stent technology – BioMimics 3D – based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering, Imperial College London) on the link between vessel geometry, blood flow mechanics and vascular disease.
ApcinteX develops and markets anticoagulant APC pathway to treat haemophilia. Apcintex has developed a new treatment that seeks to turn down the activity of a key natural anticoagulant pathway to produce normal blood clotting in patients with haemophilia. This means that the drug could potentially treat patients with all types of haemophilia, including those who develop antibodies to replacement factors. Furthermore, the drug does not cause anti-clotting antibodies to form and could be administered fortnightly by simple injection under the skin.
Concirrus Ltd. operates a cloud-based platform that connects various data sources and devices, enabling the management and organization of information from products and machines linked through the Internet. Founded in 2012, the company specializes in leveraging Internet of Things (IoT) data to transform businesses across multiple sectors, including healthcare, security, mining, insurance, and energy. Concirrus offers a range of custom solutions, including consultancy, planning, implementation, and support services, alongside pre-built applications for asset security, fleet management, smart energy, and patient monitoring. Their focus extends to providing insights and rating factors for the insurance industry, employing advanced analytics and machine learning to enhance risk management and operational efficiency. Additionally, Concirrus operates an incident monitoring center for theft recovery and asset security. The company is headquartered in London and has established strategic partnerships to further its technological offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.